Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CEFAZOLIN AND DEXTROSE | B. Braun Medical | N-050779 RX | 2000-07-27 | 2 products, RLD, RS |
CEFAZOLIN IN PLASTIC CONTAINER | Baxter | N-207131 RX | 2015-08-07 | 2 products, RLD, RS |
CEFAZOLIN SODIUM | Hikma Pharmaceuticals | N-216109 RX | 2022-10-07 | 2 products, RLD, RS |
CEFAZOLIN SODIUM | HQ Specialty Pharma | N-211413 RX | 2023-05-08 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
antiseptic skin cleanser | New Drug Application | 2024-02-13 |
cefazolin | ANDA | 2024-01-15 |
cefazolin sodium | New Drug Application | 2021-07-14 |
rugby petrolatum hydrating | C200263 | 2024-02-12 |
Expiration | Code | ||
---|---|---|---|
CEFAZOLIN SODIUM, CEFAZOLIN AND DEXTROSE, B BRAUN | |||
2023-11-23 | NPP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Surgical wound infection | D013530 | — | — | 2 | 2 | 4 | 11 | 7 | 24 |
Infections | D007239 | EFO_0000544 | — | 4 | 1 | 3 | 4 | 7 | 18 |
Wound infection | D014946 | — | — | — | — | — | 5 | 5 | 10 |
Bacteremia | D016470 | EFO_0003033 | R78.81 | — | 3 | 2 | 2 | 1 | 8 |
Obesity | D009765 | EFO_0001073 | E66.9 | 2 | — | — | 4 | — | 6 |
Antibiotic prophylaxis | D019072 | — | — | — | — | — | 2 | 4 | 6 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | — | — | 1 | 3 | — | 4 |
Staphylococcal infections | D013203 | — | A49.01 | — | — | 1 | 2 | 1 | 4 |
Endometritis | D004716 | EFO_1001312 | — | — | — | — | 1 | 2 | 3 |
Infectious arthritis | D001170 | EFO_1001351 | M00 | — | — | — | 3 | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sepsis | D018805 | HP_0100806 | A41.9 | 1 | 1 | 2 | — | — | 3 |
Cellulitis | D002481 | EFO_0003035 | L03.90 | — | 1 | 1 | — | 1 | 3 |
Keratitis | D007634 | HP_0000491 | H16 | — | — | 1 | — | 1 | 2 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | 1 | 2 |
Premature rupture fetal membranes | D005322 | HP_0001788 | O42 | — | — | 1 | — | 1 | 2 |
Infectious skin diseases | D012874 | — | — | — | — | 1 | — | — | 1 |
Bacterial skin diseases | D017192 | — | — | — | — | 1 | — | — | 1 |
Kidney calculi | D007669 | EFO_0004253 | N20 | — | — | 1 | — | — | 1 |
Chronic pancreatitis | D050500 | EFO_0000342 | K86.1 | — | — | 1 | — | — | 1 |
Hemopneumothorax | D006468 | EFO_1000963 | J94.2 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Endocarditis | D004696 | HP_0100584 | — | — | 1 | — | — | 1 | 2 |
Hyperglycemia | D006943 | HP_0003074 | R73.9 | — | 1 | — | — | — | 1 |
Critical illness | D016638 | — | — | — | 1 | — | — | — | 1 |
Fever | D005334 | HP_0001945 | R50.9 | — | 1 | — | — | — | 1 |
Pneumonia | D011014 | EFO_0003106 | — | — | 1 | — | — | — | 1 |
Cross infection | D003428 | — | — | — | 1 | — | — | — | 1 |
Systemic inflammatory response syndrome | D018746 | EFO_1001478 | R65.10 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Mammaplasty | D016462 | — | — | 1 | — | — | — | 2 | 3 |
Renal replacement therapy | D017582 | — | — | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 4 | 4 |
Appendicitis | D001064 | EFO_0007149 | K37 | — | — | — | — | 3 | 3 |
Acute cholecystitis | D041881 | EFO_1001289 | K81.0 | — | — | — | — | 2 | 2 |
Hysterectomy | D007044 | EFO_0003881 | — | — | — | — | — | 2 | 2 |
Closed fractures | D005596 | — | — | — | — | — | — | 2 | 2 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | — | 1 | 1 |
Pregnancy rate | D018873 | — | — | — | — | — | — | 1 | 1 |
Dentofacial deformities | D063169 | — | — | — | — | — | — | 1 | 1 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | — | — | — | — | 1 | 1 |
Thyroid diseases | D013959 | HP_0000820 | E00-E07 | — | — | — | — | 1 | 1 |
Drug common name | Cefazolin |
INN | cefazolin |
Description | Cefazolin is a first-generation cephalosporin compound having [(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl and (1H-tetrazol-1-ylacetyl)amino side-groups at positions 3 and 7 respectively. It has a role as an antibacterial drug. It is a cephalosporin, a member of thiadiazoles, a member of tetrazoles and a beta-lactam antibiotic allergen. It is a conjugate acid of a cefazolin(1-). |
Classification | Small molecule |
Drug class | cephalosporins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1 |
PDB | — |
CAS-ID | 25953-19-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1435 |
ChEBI ID | 474053 |
PubChem CID | 33255 |
DrugBank | DB01327 |
UNII ID | IHS69L0Y4T (ChemIDplus, GSRS) |